| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 113,192 | 85,169 | 76,808 | 125,464 | | Cost of Revenue | 73,093 | 60,526 | 54,908 | 84,855 | | | Gross Profit | 40,099 | 24,643 | 21,900 | 40,609 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,742 | 29,870 | 25,338 | 31,923 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,357 | (5,227) | (3,438) | 8,686 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (659) | 307 | 357 | 399 | | Earnings Before Interest And Taxes | 8,523 | (4,920) | (3,081) | 9,085 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 8,523 | (4,920) | (3,081) | 9,085 | | Income Tax Expense | 3,450 | (1,834) | (1,423) | 2,788 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,073 | (3,086) | (1,658) | 6,297 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,073 | (3,086) | (1,658) | 6,297 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,073 | ($3,086) | ($1,658) | $6,297 |
|
0.51% Nasdaq 
0.06 (0.48%) 
Income Statement
